Test ID FLEP Leptin
Specimen Required
Specimen Type: Serum
Container/Tube: Red or SST
Specimen Volume: 1 mL
Collection Instructions: Draw blood in a plain red-top tube(s), serum gel tube(s) is acceptable. Spin down and send 1 mL of serum ambient in a plastic vial.
Note: EDTA (lavender-top) plasma is an acceptable alternate.
Method Name
Enzyme Immunoassay (EIA)
Reporting Name
LeptinSpecimen Type
SerumSpecimen Minimum Volume
0.5 mL
NOTE: Minimum volume does not allow for repeat analysis.
Specimen Stability Information
Specimen Type | Temperature | Time |
---|---|---|
Serum | Ambient (preferred) | 14 days |
Refrigerated | 30 days | |
Frozen | 21 days |
Reference Values
Units: ng/mL
Female Ranges <20 by Body Mass Index (BMI)
BMI |
Tanner Stage 1-2 |
Tanner Stage 3-4 |
Tanner Stage 5 |
11 |
0.3-1.5 |
0.4-1.3 |
0.7-2.7 |
12 |
0.4-1.9 |
0.5-1.6 |
0.8-3.2 |
13 |
0.5-2.4 |
0.7-2.1 |
0.9-3.7 |
14 |
0.6-3.1 |
0.8-2.6 |
1.0-4.3 |
15 |
0.8-3.9 |
1.1-3.3 |
1.2-5.0 |
16 |
1.1-5.0 |
1.3-4.2 |
1.4-5.8 |
17 |
1.4-6.5 |
1.7-5.3 |
1.6-6.7 |
18 |
1.7-8.3 |
2.1-6.7 |
1.9-7.8 |
19 |
2.2-10.7 |
2.7-8.5 |
2.2-9.1 |
20 |
2.9-13.7 |
3.4-10.7 |
2.6-10.5 |
21 |
3.7-17.6 |
4.3-13.6 |
3.0-12.3 |
22 |
4.7-22.6 |
5.5-17.2 |
3.5-14.2 |
23 |
6.0-29.0 |
6.9-21.8 |
4.0-16.6 |
24 |
7.8-37.2 |
8.8-27.6 |
4.7-19.3 |
25 |
10.0-47.8 |
11.1-34.9 |
5.5-22.4 |
26 |
12.8-61.4 |
14.0-44.2 |
6.4-26.0 |
27 |
16.4-78.8 |
17.7-56.0 |
7.4-30.3 |
28 |
21.5-101.0 |
22.5-70.9 |
8.6-35.2 |
29 |
27.0-130.0 |
28.4-89.7 |
10.0-40.9 |
30 |
|
36.0-114.0 |
11.6-47.6 |
31 |
|
45.6-144.0 |
13.5-55.3 |
32 |
|
57.7-144.0 |
15.7-64.4 |
33 |
|
|
18.3-74.9 |
34 |
|
|
21.2-87.0 |
35 |
|
|
24.7-101.0 |
36 |
|
|
28.7-118.0 |
37 |
|
|
33.4-137.0 |
Male Ranges <20 by Body Mass Index (BMI)
BMI |
Tanner Stage 1-2 |
Tanner Stage 3-4 |
Tanner Stage 5 |
11 |
0.1-0.7 |
0.1-0.6 |
0.1-0.5 |
12 |
0.2-0.9 |
0.1-0.7 |
0.1-0.5 |
13 |
0.2-1.2 |
0.1-0.9 |
0.1-0.6 |
14 |
0.3-1.6 |
0.1-1.1 |
0.1-0.7 |
15 |
0.4-2.0 |
0.1-1.3 |
0.1-0.8 |
16 |
0.5-2.7 |
0.2-1.6 |
0.1-1.0 |
17 |
0.6-3.5 |
0.2-1.6 |
0.1-1.1 |
18 |
0.8-4.6 |
0.2-2.5 |
0.2-1.3 |
19 |
1.0-6.0 |
0.3-3.0 |
0.2-1.5 |
20 |
1.4-7.9 |
0.3-3.7 |
0.2-1.7 |
21 |
1.8-10.4 |
0.4-4.6 |
0.2-2.0 |
22 |
2.3-13.6 |
0.5-5.6 |
0.3-2.3 |
23 |
3.1-17.8 |
0.6-6.9 |
0.3-2.7 |
24 |
4.0-23.3 |
0.8-8.5 |
0.4-3.6 |
25 |
5.2-30.6 |
1.0-10.5 |
0.4-3.1 |
26 |
6.9-40.1 |
1.2-12.9 |
0.5-4.2 |
27 |
9.0-52.5 |
1.5-15.8 |
0.6-4.8 |
28 |
11.8-68.9 |
1.8-19.4 |
0.6-5.6 |
29 |
15.5-90.3 |
2.2-23.9 |
0.7-6.5 |
30 |
20.3-118.0 |
2.7-29.4 |
0.9-7.5 |
31 |
|
3.3-36.2 |
1.0-8.7 |
32 |
|
4.1-44.5 |
1.2-10.0 |
33 |
|
5.0-54.7 |
1.3-11.6 |
34 |
|
6.2-67.2 |
1.5-13.4 |
35 |
|
7.6-82.6 |
1.8-15.6 |
36 |
|
9.4-101.0 |
2.1-18.0 |
37 |
|
11.5-124.0 |
2.4-20.8 |
38 |
|
|
2.8-24.1 |
39 |
|
|
3.2-27.9 |
40 |
|
|
3.7-32.3 |
Female Ranges >19 by Body Mass Index (BMI)
BMI |
Range |
BMI |
Range |
11 |
0.7-3.6 |
24 |
4.4-24.2 |
12 |
0.8-4.2 |
25 |
5.1-28.0 |
13 |
0.9-4.8 |
26 |
5.9-32.4 |
14 |
1.0-5.6 |
27 |
6.8-37.5 |
15 |
1.2-6.5 |
28 |
7.9-43.5 |
16 |
1.4-7.5 |
29 |
9.1-50.4 |
17 |
1.6-8.7 |
30 |
10.6-58.3 |
18 |
1.8-10.0 |
31 |
12.2-67.5 |
19 |
2.1-11.6 |
32 |
14.1-78.2 |
20 |
2.4-13.4 |
33 |
16.4-90.5 |
21 |
2.8-15.6 |
34 |
19.0-105.0 |
22 |
3.3-18.0 |
35 |
22.0-121.0 |
23 |
3.8-20.9 |
36 |
25.4-141.0 |
Male Ranges >19 by Body Mass Index (BMI)
BMI |
Range |
BMI |
Range |
11 |
0.1-0.4 |
25 |
1.1-9.6 |
12 |
0.1-0.6 |
26 |
1.3-12.0 |
13 |
0.1-0.7 |
27 |
1.6-14.9 |
14 |
0.1-0.9 |
28 |
2.0-18.6 |
15 |
0.1-1.1 |
29 |
2.5-23.2 |
16 |
0.2-1.3 |
30 |
3.2-28.9 |
17 |
0.2-1.7 |
31 |
3.9-36.0 |
18 |
0.2-2.1 |
32 |
4.9-44.9 |
19 |
0.3-2.6 |
33 |
6.1-55.8 |
20 |
0.4-3.2 |
34 |
7.6-69.6 |
21 |
0.4-4.0 |
35 |
9.5-86.7 |
22 |
0.5-5.0 |
36 |
11.8-108.0 |
23 |
0.8-6.2 |
37 |
14.8-135.0 |
24 |
0.9-7.7 |
|
|
Day(s) Performed
Tuesday, Thursday
Report Available
4 to 15 daysPerforming Laboratory
Esoterix EndocrinologyTest Classification
This test was developed and its performance characteristics determined by LabCorp. It has not been cleared or approved by the Food and Drug Administration.CPT Code Information
83520